Form EFFECT Adaptimmune Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 14, 2025 |
| Accession Number: | 0001104659-25-103158 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. Navy Invites Avocados From Peru to Participate in America's Historic 250th Anniversary Maritime Celebration
- John Legend's Musical Journey with Singer: Chinese Netizens Hail a "Masterclass"
- New Vaccine Gives Brain Cancer Patients Hope of Longer Survival
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
